Branford, S., Kim, D., Soverini, S., Haque, A., Shou, Y., Woodman, R. C., . . . Müller, M. C. (2012). Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib. J Clin Oncol.

Branford, Susan, et al. "Initial Molecular Response At 3 Months May Predict Both Response and Event-Free Survival At 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib." J Clin Oncol 2012.

Branford, Susan, et al. "Initial Molecular Response At 3 Months May Predict Both Response and Event-Free Survival At 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib." J Clin Oncol 2012.